Synthesis, characterization and in vitro antitumor activity of three organotin(IV) complexes with carbazole ligand

Three novel organotin(IV) complexes with 2-(9H-carbazol-9-yl) acetic acid (HL), of the formulae {[nBu₂SnOL]₂O}₂ (1), [nBuSn(O)OL]₆ (2) and [nBu₃SnOL]₆ (3) were prepared. All compounds were characterized by X-ray crystallography, confirming that complex (1) is tetranuclear one with ladder framework, complex (2) is a hexanuclear organotin(IV) complex with drum structure and complex (3) is a macrocycle with 24-membered stannoxane ring. Furthermore, all complexes were tested in vitro for their cytotoxic activity, using human hepatocellular carcinoma cell line (BEL-7402) and human hepatocellular liver carcinoma cell line (HepG2). Complex (1) displayed the best cytotoxicity and can be pointed out as a promising substrate to be subject of further investigations.     

Syntheses, characterization and crystal structure of diorganotin and triorganotin heterocyclicdicarboxylates with monomeric, 2D network and 3D framework structures

A series of new diorganotin and triorganotin(IV) heterocyclicdicarboxylates [(ⁿBu₃Sn)₂(2,5-pdc)]_∞ (1), {[(2-FC₆H₄CH₂)₃Sn]₂(2,5-pdc)}_∞ (2), {[(2-ClC₆H₄CH₂)₃Sn]₂(2,5-pdc)}_∞ (3), {[(4-CNC₆H₄CH₂)₃Sn]₂(2,5-pdc)}_∞ (4), {[(4-ClC₆H₄CH₂)₃Sn]₂(2,5-pdc)}_∞ (5), [(Ph)₂Sn(2,6-pdc)(H₂O)]_∞ (6), {[ⁿBu₃Sn(2,6-pdc)SnⁿBu₃]₂(H₂O)₂} · C₂H₃N (7) and {[Ph₃Sn(2,3-pdz)SnPh₃]₂(H₂O)} (8) have been obtained by reactions of diorganotin(IV) and triorganotin (IV) oxide with 2,6 or 2,5-H₂pdc (pdc = pyridinedicarboxylate) or 2,3-H₂pdz (pdz = pyrazinedicarboxylate). Complexes 1-8 were characterized by elemental, IR and NMR spectra analyses. The crystal and molecular structures of compounds 1, 6, 7 and 8 have been determined by X-ray single crystal diffraction. Compound 1 has 2D network structures. Compound 6 has 1D polymeric chain and 3D framework supramolecular structures due to the coordinated water molecules. Compound 7 has a monomeric structure, but the supramolecular structures are network.     

Synthesis, characterization, crystal structure and antitumor activity of organotin(IV) compounds bearing ferrocenecarboxylic acid

Four new organotin(IV) complexes [(Bu₃Sn)(FcCOO)]_n (1), [(μ-Bu₂Sn)₂(μ-Bu₂SnFcCOO)₂(μ₃-O)₂(μ-OCH₃)₂]₂ (2), [Ph₃Sn(FcCOO)(H₂O)](phen) (3) and [{Ph₃Sn(FcCOO)}₂(4,4′-bipy)] (4) [Fc = (η⁵-C₅H₅)Fe(η⁵-C₅H₄)] have been synthesized and characterized by elemental analyses, IR, (¹H and ¹³C) NMR spectra and X-ray single-crystal diffraction analyses. The structure analyses show that all tin atoms in complexes 1-4 are five-coordinated with trigonal bipyramid geometry. Complexes 1-4 and FcCOOH undergo reversible one-electron oxidations in methanol solution. The antitumor activities of complexes 1-4 have also been tested. Complexes 1 and 2 exhibit medium activity towards P388 cell lines and Hela cell lines. Complexes 3 and 4 exhibit medium activity towards P388 cell lines but strong activity towards Hela cell lines. This may result from complexes 3 and 4 including the neutral molecules 1,10-phenanthroline and 4,4′-bipy.     

Synthesis and structures of aryloxo- and binaphthoxogermanium(IV) alkyl iodide complexes

The germanium(II) aryloxide complexes (S)-[Ge{O₂C₂₀H₁₀-(SiMe₂Ph)₂-3,3′}{NH₃}] (1) and [Ge(OC₆H₃Ph₂-2,6)₂] (2) react with either Bu^tI or MeI to yield the corresponding germanium(IV) compounds (S)-[Ge{O₂C₂₀H₁₀-(SiMe₂Ph)₂-3,3′}{Bu^t}{I}] (3), (S)-[Ge{O₂C₂₀H₁₀-(SiMe₂Ph)₂-3,3′}{Me}{I}] (4), [Ge(OC₆H₃Ph₂-2,6)₂(Bu^t)(I)] (5), and [Ge(OC₆H₃Ph₂-2,6)₂(Me)(I)] (6). Compound 6 reacts with 2,6-diphenylphenol to yield [Ge(OC₆H₃Ph₂-2,6)₃(Me)] (7), while 3-5 do not. The X-ray crystal structures of 3-5 and 7 were determined, and 3-5 represent the first structurally characterized germanium(IV) species having germanium bound to both oxygen and iodine.     

Organotin meclofenamic complexes: Synthesis, crystal structures and antiproliferative activity of the first complexes of meclofenamic acid - Novel anti-tuberculosis agents

The complexes [Me₂(Meclo)SnOSn(Meclo)Me₂]₂ (2) and [Ph₃Sn(Meclo)] (3) where HMeclo is meclofenamic acid, N-(2,6-dichloro-m-tolylanthranilic acid)], have been prepared and structurally characterized by means of vibrational, ¹H and ¹³C NMR spectroscopies. The crystal structure of complexes (2) and (3) have been determined by X-ray crystallography. Three distannoxane rings are present to the dimeric tetraorganodistannoxane of planar ladder arrangement of (2). The structure is centro symmetric and features a central rhombus Sn₂O₂ unit two additional tin atoms linked at the oxygen atoms. Five- and six-coordinated tin centers are present in the dimer distannoxane. X-ray analysis of (3) revealed a penta-coordinated structure containing Ph₃Sn coordinated to the chelated carboxylato group. The polar imino hydrogen atom participates in intra-molecular hydrogen bonds. Complexes (2) and (3) are self-assembled via π → π, C-H-π, stacking interactions and intra-molecular hydrogen bonds. Meclofenamic acid and [Ph₃Sn(Meclo)] have been evaluated for antiproliferative activity in vitro against three human cancer cell lines: MCF-7 (human breast cancer cell line), T24 (bladder cancer cell line), A-549 (non-small cell lung carcinoma) and a mouse L-929 (a fibroblast-like cell line cloned from strain L). The [Ph₃Sn(Meclo)] complex exhibited high cytotoxic activity against all the cancer cell lines. Meclofenamic and [Ph₃Sn(Meclo)] were tested for anti-mycobacterial activity against Mycobacterium tuberculosis H37Rv. The [Ph₃Sn(Meclo)] complex was found to be a promising anti-mycobacterial lead compound, displaying high activity against M. tuberculosis H37Rv.     

Synthesis, crystal structures, cytotoxicity and qualitative structure-activity relationship (QSAR) of cis-bis{5-[(E)-2-(aryl)-1-diazenyl]quinolinolato}di-n-butyltin(IV) complexes, (n)Bu2Sn(L)2

A series of cis-bis{5-[(E)-2-(aryl)-1-diazenyl]quinolinolato}di-n-butyltin(IV) complexes has been synthesized and characterized by ¹H-, ¹³C-, ¹¹⁹Sn NMR, ESI-MS (electrospray ionization mass spectrometry), IR and ^119mSn Mössbauer spectroscopic techniques in combination with elemental analyses. The structures of four di-n-butyltin(IV) complexes, viz., ⁿBu₂Sn(L³)₂ (3), ⁿBu₂Sn(L⁴)₂ (4), ⁿBu₂Sn(L⁵)₂ (5) and ⁿBu₂Sn(L⁷)₂ · 0.5C₆H₆ (7) (LH = 5-[(E)-2-(aryl)-1-diazenyl)quinolin-8-ol) were determined by single crystal X-ray diffraction. In general, the complexes were found to adopt a distorted cis-octahedral arrangement around the tin atom. These complexes retain their solid-state structure in non-coordinating solvent as evidenced by ¹¹⁹Sn and ¹³C NMR spectroscopic results. The in vitro cytotoxicity of di-n-butyltin(IV) complexes (3-8) is reported against seven well characterized human tumour cell lines. The basicity of the two quinolinolato donor N and O atoms of the ligands are discussed in relation to the cytotoxicity data.     

Substituted pyridylmethylamide ligands and their zinc complexes

Mononuclear zinc complexes of a family of pyridylmethylamide ligands abbreviated as HL, HL^Ph, HL^Me3, HL^Ph3, and MeL^SMe [HL = N-(2-pyridylmethyl)acetamide; HL^Ph = 2-phenyl-N-(2-pyridylmethyl)acetamide; HL^Me3 = 2,2-dimethyl-N-(2-pyridylmethyl)propionamide; HL^Ph3 = 2,2,2-triphenyl-N-(2-pyridylmethyl)acetamide; MeL^SMe = N-methyl-2-methylsulfanyl-N-pyridin-2-ylmethyl-acetamide] were synthesized and characterized spectroscopically and by single crystal X-ray structural analysis. The reaction of zinc(II) salts with the HL ligands yielded complexes [Zn(HL)₂(OTf)₂] (1), [Zn(HL)₂(H₂O)](ClO₄)₂ (2), [Zn(HL^Ph3)₂(H₂O)](ClO₄)₂ (3), [Zn(HL^Ph)Cl₂] (4), [Zn(HL^Me3)Cl₂] (5), and [Zn(MeL^SMe)Cl₂] (6). The complexes are either four-, five- or six-coordinate, encompassing a variety of geometries including tetrahedral, square-pyramidal, trigonal-bipyramidal, and octahedral.     

The triphenyltin(VI) complexes of NSAIDs and derivatives. Synthesis, crystal structure and antiproliferative activity. Potent anticancer agents

The novel triphenyltin(IV) esters of flufenamic acid (1), Hflu, [Ph₃Sn(flu)] (2), and of [2-(2,3-dichlorophenylamino)benzoic acid] (3), Hdcpa, [Ph₃Sn(dcpa)] (4) have been structurally characterized by means of vibrational and ¹H, ¹³C NMR spectroscopic studies. The crystal and molecular structures of [SnPh₃(dcpa)(DMSO)] 4a are described. The molecular structure of 4a reveals that the Sn atom has a distorted trigonal bipyramidal coordination geometry with equatorial phenyl groups and the carboxylate and dimethylsulfoxide oxygen atoms occupying axial positions. The crystal structure of 4a is self-assembled by C-H---π and π-π stacking interactions. The in vitro cytotoxic activity of 1-4 and of the related non-steroidal anti-inflammatory drugs, NSAIDs, [2-(2,6-dimethylphenylamino)benzoic acid], Hdmpa (5), [Ph₃Sn(dmpa)] (6), [2-(2,3-dimethylphenylamino)benzoic acid], mefenamic acid, Hmef (7) and [Ph₃Sn(mef)] (8) has been evaluated against the cancer cell lines MCF-7, T-24, A-549 and L-929. The ligands exhibited very poor cytotoxic activity against the four cancer cell lines. Complex 6 exhibits the highest activity and selectivity against A-549 and MCF-7 cancer cell lines and complex 8 the highest activity and selectivity against T-24 cancer cell line. The cytotoxic results indicate that coupling of Hdmpa and Hmef with R₃Sn(IV) metal center results in complexes with important biological properties and remarkable cytotoxic activity, since they display IC₅₀ values in a μΜ range better to that of the antitumor drug cis-platin. Complexes 6 and 8 are considered as excellent antitumor compounds and the results of this study represent the discovery of triphenyltin(IV)esters as a potential novel class of anticancer agents.     

Synthesis, structures and magnetic properties of 1D to 3D coordinated polymers based on series of flexible sulfide ligands

Five complexes [Mn₂O(L₁)₄]_n (1), [Co(L₂)(H₂O)₂]_n (2), [Co(L₃)₂(H₂O)₂]_n (3) and [Co(L₄)₂(4,4′-bpy)(H₂O)]_n (4) were obtained by using flexible organic ligands HL₁, HL₂, HL₃, and HL₄ in hydrothermal systems with cobalt, copper and manganese salts respectively (HL₁ = 2-(4-pyridylmethylthio)benzoic acid, HL₂ = 4-(4-pyridylmethylthio)benzoic acid, HL₃ = 2-(3-pyridylmethylthio)benzoic acid, HL₄ = 4-(2-pyridylmethylthio)benzoic acid). The five complexes have been characterized by X-ray single crystal diffraction, FT-IR spectrum and elemental analysis. Complex 1 is assembled to a 3D porous framework with Mn₂O units as nodes. Complex 2 shows 2D layer networks comprised of six-coordinated Co²⁺ centers and L₂⁻ anionic ions. Complexes 3 and 4 have different 1D double or single chain structures. Various non-covalent bonds such as hydrogen bonds, π?π interactions, H-bond grids and S?S weak interactions lead to interesting supramolecular frameworks. DC (direct current) temperature dependent magnetic susceptibilities suggest weak antiferromagnetic behaviors exist in 1, and single ion paramagnetic along with spin-orbit coupling behavior dominate in 3 and 4.     

First microwave-assisted synthesis of an electron-rich phosphane and its coordination chemistry with platinum(II) and palladium(II)

The P-O ligand 3-(di(2-methoxyphenyl)phosphanyl)propionic acid (HL) was synthesized by a microwave-assisted reaction of a secondary phosphane. The coordination of HL to Pt^II yielded the neutral mononuclear complex trans-[PtCl(κ²-P,O-L)(κ-P-HL)] (1), while the reaction of PdClMe(η⁴-COD) (COD = 1,4-cyclooctadiene) with HL in the presence of NEt₃ gave the anionic Pd^II compound of the formula (HNEt₃)[PdClMe(κ²-P,O-L)] (2). Upon crystallization of the latter compound the neutral chloride-bridged dimetallic compound cis-[Pd(μ-Cl)Me(HL)]₂ (3) was obtained. HL, 1 and 3·CH₂Cl₂ have been characterized by single crystal X-ray structure analyses.     

Organotin(IV) 4-methoxyphenylethanoates: Synthesis, spectroscopic characterization, X-ray structures and in vitro anticancer activity against human prostate cell lines (PC-3)

A series of organotin(IV) carboxylates, [Bu₂SnL₂] (1), [Et₂SnL₂] (2), [Me₂SnL₂] (3), [Bu₃SnL]_n(4), [Me₆Sn₂L₂]_n(5), [Ph₃SnL]_n(6) and [Oct₂SnL₂] (7), where L = O₂CCH₂C₆H₄OCH₃-4, have been synthesized. These complexes have been characterized by elemental analysis, FT-IR and multinuclear NMR (¹H, ¹³C and ¹¹⁹Sn). Based on spectroscopic results, the ligand appeared to coordinate to the Sn atom through COO moiety. Single crystal analysis has shown a bridging behavior of ligand in tributyl- and trimethyltin(IV) derivatives, and a chelating bidentate mode in diethyltin(IV) complex. Bioassay results have shown that these compounds have good antibacterial, antifungal and antitumor activity. The activity against prostate cancer cell lines (PC-3) decreased in the order 1 > 5 > 2 > 3 > 7.     

Half-sandwich ruthenium thiocarbonate complexes: Structures of CpRu(PPh3)2SCO2Bu, CpRu(dppe)SCO2Bu and CpRu(PPh3)(CO)SCO2Bu

Thiocarbonate ruthenium complexes of the form CpRu(L)(L′)SCO₂R (L = L′ = PPh₃ (1), 1/2 dppe (2), L = PPh₃, L′ = CO (3); R = Et (a), Buⁿ (b), C₆H₅ (c), 4-C₆H₄NO₂ (d)) have been synthesized by the reaction of the corresponding sulfhydryl complexes, CpRu(L)(L′)SH, with chloroformates, ROCOCl, at low temperature. The bis(triphenylphosphine) complexes 1 can be converted to 3 under CO atmosphere. The crystal structures of CpRu(PPh₃)₂SCO₂Buⁿ (1b), CpRu(dppe)SCO₂Buⁿ (2b), and CpRu(PPh₃)(CO)SCO₂Buⁿ (3b) are reported.     

Syntheses and characterization of diorganotin(IV) derivatives with areneseleninic acid: X-ray crystal structures of 1D infinite chains containing eight-membered ring

Three new diorganotin(IV) complexes, [Bu₂Sn(O₂SeC₆H₅)₂]_n (1), [Bu₂Sn(O₂SeC₆H₄Me)₂]_n (2), [Me₂Sn(O₂SeC₆H₄Bu)₂]_n (3) have been synthesized by the reaction of benzeneseleninic acid, p-tolueneseleninic acid, and 4-tert-butylbenzeneseleninic acid with Me₂SnCl₂ or Bu₂SnCl₂ in the presence of sodium ethoxide in methanol at 50 °C. All of the complexes were characterized by elemental analysis, FT-IR, NMR (¹H, ¹³C and ¹¹⁹Sn) spectroscopy and X-ray crystallography. X-ray diffraction studies of 1, 2, 3 show that the areneseleninate groups behave as double bridges between the tin atoms leading to polymeric chain structure with Sn₂O₄Se₂ eight-membered ring. The organic groups bonded to the tin atoms are in trans-position in the resulting octahedral arrangement.     

Complexes of N-thiophosphorylthioureas RNHC(S)NHP(S)(OiPr)2 (HL) (R = pyridin-2-yl, pyridin-3-yl, 6-amino-pyridin-2-yl) with copper(I): Crystal structures of Cu(PPh3)nL (n = 1, 2)

Reaction of the potassium salts of N-thiophosphorylated thioureas of common formula RNHC(S)NHP(S)(OiPr)₂ [R = pyridin-2-yl (HL^a), pyridin-3-yl (HL^b), 6-amino-pyridin-2-yl (HL^c)] with Cu(PPh₃)₃I in aqueous EtOH/CH₂Cl₂ leads to mononuclear [Cu(PPh₃)₂L^a,b-S,S′] (1, 2) and [Cu(PPh₃)L^c-S,S′] (3) complexes. Using copper(I) iodide instead of Cu(PPh₃)₃I, polynuclear complexes [Cu_n(L-S,S′)_n] (4-6) were obtained. The structures of these compounds were investigated by IR, ¹H, ³¹P{¹H} NMR spectroscopy, ES-MS and elemental analyses. The crystal structures of Cu(PPh₃)₂L^b (2) and Cu(PPh₃)L^c (3) were determined by single-crystal X-ray diffraction.     

Chiral 2-pyridyl alcoholate copper complexes: crystal structures of [bis(2-pyridyl alcoholate)copper(II)] and the use of [(2-pyridyl alcoholate)copper(II)]and [(2-pyridyl alcoholate)copper(I)] in asymmetric cyclopropanation of styene and allylic oxidation of cyclohexene

Chiral N,O pyridine alcohols HL¹-HL⁶ were used to form complexes with copper(II) ions. Ligands HL¹ and HL² formed complexes with copper(II) ions when Cu(OAc)₂ and HL were refluxed in methanol/ethanol mixture. Ligand HL³ formed a complex with copper(II) when deprotonated with NaH and stirred in a Cu(II) acetate THF solution. Ligands HL⁴-HL⁶ did not form complexes with copper(II) under similar conditions. Two complexes, [Cu(L¹)₂] and [Cu(L²)₂], were isolated as single crystals and characterized by X-ray crystallography. These complexes showed low catalytic activities in asymmetric reactions. However, they became active when reacted with triflic acid. Copper complexes, [Cu(L)] or [Cu(L)]⁺, formed in situ by reacting ligands HL with copper(I) or (II) ions, respectively, were also found to be active copper catalysts for asymmetric cyclopropanation of styrene with ethyl diazoacetate and allylic oxidation of cyclohexene with t-butylperoxybenzoate. Enantioselectivities up to 56% and 38% were obtained in asymmetric cyclopropanation of styrene and asymmetric allylic oxidation of cyclohexene, respectively.     

Mononuclear iron(III) complexes supported by tripodal N3O ligands: Synthesis, structure and reactivity towards DNA cleavage

A new synthetic route to the known tripodal tetradentate N₃O ligand L¹ (HL¹ = [N-(3,5-di-tert-butyl-2-hydroxybenzyl)-N,N-di-(2-pyridylmethyl)]amine) is reported. The related compounds HLⁿ (n = 2, 3) were prepared by a similar procedure. Treatment of HLⁿ (n = 1-3) with FeCl₃·6H₂O in hot methanol led to the mononuclear iron(III) complexes [Fe(Lⁿ)Cl₂] (1: n = 1, 2: n = 2, 3: n = 3). The solid-state structures of complexes 1 and 2 were determined by X-ray crystallography. [Fe(L¹)Cl₂] (1) showed effective nuclease activity in the presence of hydrogen peroxide, converting supercoiled plasmid DNA to its linear form.     

Combining coordination chemistry with hydrogen bonds: perturbation of the structures by interaction of an organotin(IV) complex with O-donor solvent molecules

We have examined the role of different solvents in the crystallisation process of cis-octahedral, diphenyltin(IV)-bis-cupferronato complex, Ph₂Sn(cupf)₂ (1), where . The Mössbauer spectra of frozen chloroform solution of 1 revealed the presence of cis and trans isomers. This cis-trans isomerisation was investigated by Mössbauer spectroscopy and the results inspired the synthesis of two new heptacoordinated derivatives: Ph₂Sn(cupf)₂(H₂O) (2) and Ph₂Sn(cupf)₂(EtOH) · EtOH (3). In both compounds, the O-donor solvent molecules (H₂O, EtOH) form novel Sn-O bonds with the Ph₂Sn(IV) centre of 1, consequently the phenyl groups attached to tin undergo an intramolecular rearrangement. Compound 2 contains O-H ? O hydrogen bonded infinite chains. In compound 3, O-H ? O hydrogen-bonds and short O ? O contacts assemble the complexes and uncoordinated solvent molecules into dimeric supramolecules. These solvents have structure-determining roles at both molecular and supramolecular levels: at molecular level the coordination of solvent determines intramolecular rearrangement by changing the conformation of the parent unsolvated complex, whilst at supramolecular level they control the association of solvated molecules via hydrogen bonds.     

Effect of metal coordination and intra-molecular H-bond on the acidity of phenolic proton in a set of structurally characterized octahedral Ni(II) complexes of l-histidine derivative

Four different mononuclear octahedral Ni(II) complexes with protonated and deprotonated form of the same ligand have been synthesized by controlling reaction conditions and structurally characterized. The complexes are [Ni(HL^l-his)(benzoate)(MeOH)] (1), [Ni(HL^l-his)(SCN)(MeOH)] (2), [Ni(HL^l-his)₂] (3) and [Ni(L^l-his)(imidazole)₂] (4) where H₂L^l-his is (S)-2-(2-hydroxybenzylamino)-3-(1H-imidazol-4-yl)-propionic acid. The ligand behaves as a monobasic tetradentate ligand in 1 and 2, monobasic tridentate ligand in 3 and dibasic tetradentate ligand in 4. Ni(II) coordinated phenolic proton of the ligand in the complexes 1-2 shows strong intra-molecular H-bonding with benzoate in 1 and lattice water in 2, whereas 3 shows intermolecular H-bonding between uncoordinated phenols with neighbouring carboxylate. The pH titration of the complexes revealed that metal coordination and H-bond in complexes 1 and 2 considerably lowers the acidity of ligand phenol (pK_a 6.8 and 7.0 respectively) compared to phenol (pK_a 10). The complex 4 does not show any proton loss due to the absence of phenolic proton. All the complexes show extensive H-bonded network in the crystals including narrow (7.8 × 5.2 Å) water filled one dimensional channel in 2.     

Synthesis and structural characterization of the mono- and diphosphine-containing diiron propanedithiolate complexes related to [FeFe]-hydrogenases. Biomimetic H2 evolution catalyzed by (mu-PDT)Fe2(CO)4[(Ph2P)2N(n-Pr)

As the new H-cluster models, six diiron propanedithiolate (PDT) complexes with mono- and diphosphine ligands have been prepared and structurally characterized. The monophosphine model complex (μ-PDT)Fe₂(CO)₅[Ph₂PNH(t-Bu)] (1) was prepared by reaction of parent complex (μ-PDT)Fe₂(CO)₆ (A) with 1 equiv of Ph₂PNH(t-Bu) in refluxing xylene, whereas A reacted with 1 equiv of Me₃NO · 2H₂O in MeCN at room temperature followed by 1 equiv of Ph₂PH to give the corresponding monophosphine model complex (μ-PDT)Fe₂(CO)₅(Ph₂PH) (2). Further treatment of 2 with 1 equiv of n-BuLi in THF at −78 °C followed by 1 equiv of CpFe(CO)₂I from −78 °C to room temperature afforded monophosphine model complex (μ-PDT)Fe₂(CO)₅[Ph₂PFe(CO)₂Cp] (3), whereas the diphosphine model complexes (μ-PDT)Fe₂(CO)₄(Ph₂PC₂H₄PPh₂) (4), (μ-PDT)Fe₂(CO)₄[(Ph₂P)₂N(n-Pr)] (5) and (μ-PDT)Fe₂(CO)₄[(Ph₂P)₂N(n-Bu)] (6) were obtained by reactions of A with ca.1 equiv of the corresponding diphosphines in refluxing xylene. All the new model complexes were characterized by elemental analysis, spectroscopy and particularly for 1 and 3-6 by X-ray crystallography. On the basis of electrochemical and spectroelectrochemical studies, model 5 was found to be a catalyst for HOAc proton reduction to H₂, and for this electrocatalytic reaction an ECCE mechanism was proposed.     

Synthesis, protonation and electrochemical properties of trinuclear NiFe2 complexes Fe2(CO)6(μ3-S)2[Ni(Ph2PCH2)2NR] (R = n-Bu, Ph) with an internal pendant nitrogen base as a proton relay

Two trinuclear NiFe₂ complexes Fe₂(CO)₆(μ₃-S)₂[Ni(Ph₂PCH₂)₂NR] (R = n-Bu, 1; Ph, 2) containing an internal base were prepared as biomimetic models for the active sites of FeFe and NiFe hydrogenases. Treatment of complex Fe₂(CO)₆(μ₃-S)₂[Ni(Ph₂PCH₂)₂N(n-Bu)] (1) with HOTf gave an N-protonated complex [Fe₂(CO)₆(μ₃-S)₂{Ni(Ph₂PCH₂)₂NH(n-Bu)}][OTf] ([1H][OTf]). The structures of complexes 1, 2 and [1H][OTf] were determined by X-ray crystallography, which shows that the proton held by the N atom of [1H][OTf] lies in an equatorial position. Cyclic voltammograms of complexes 1 and [1H][OTf] were studied and compared with that of Fe₂(CO)₆(μ₃-S)₂[Ni(dppe)].